DrugPatentWatch Database Preview
Details for Patent: 8,128,960
Which drugs does patent 8,128,960 protect, and when does it expire?
Patent 8,128,960 protects TRIESENCE and is included in one NDA.
This patent has twenty-five patent family members in twenty-one countries.
Summary for Patent: 8,128,960
| Title: | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| Abstract: | Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection. |
| Inventor(s): | Kabra; Bhagwati P. (Euless, TX), Sarkar; Ruma (Fort Worth, TX) |
| Assignee: | Alcon Research, Ltd. (Fort Worth, TX) |
| Application Number: | 12/401,168 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; |
Drugs Protected by US Patent 8,128,960
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,128,960
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 070824 | Start Trial | |||
| Australia | 2009223649 | Start Trial | |||
| Brazil | PI0909630 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
